213 related articles for article (PubMed ID: 24464531)
1. Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users.
Marks KR; Lile JA; Stoops WW; Rush CR
Psychopharmacology (Berl); 2014 Jul; 231(14):2741-50. PubMed ID: 24464531
[TBL] [Abstract][Full Text] [Related]
2. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121
[TBL] [Abstract][Full Text] [Related]
3. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.
Comer SD; Mogali S; Saccone PA; Askalsky P; Martinez D; Walker EA; Jones JD; Vosburg SK; Cooper ZD; Roux P; Sullivan MA; Manubay JM; Rubin E; Pines A; Berkower EL; Haney M; Foltin RW
Neuropsychopharmacology; 2013 Nov; 38(12):2427-38. PubMed ID: 23736314
[TBL] [Abstract][Full Text] [Related]
4. Alprazolam attenuates the behavioral effects of d-amphetamine in humans.
Rush CR; Stoops WW; Wagner FP; Hays LR; Glaser PE
J Clin Psychopharmacol; 2004 Aug; 24(4):410-20. PubMed ID: 15232333
[TBL] [Abstract][Full Text] [Related]
5. Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance.
Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
Drug Alcohol Depend; 2011 Dec; 119(3):187-93. PubMed ID: 21737214
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
Jayaram-Lindström N; Konstenius M; Eksborg S; Beck O; Hammarberg A; Franck J
Neuropsychopharmacology; 2008 Jul; 33(8):1856-63. PubMed ID: 17957221
[TBL] [Abstract][Full Text] [Related]
7. Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats.
Todtenkopf MS; O'Neill KS; Kriksciukaite K; Turncliff RZ; Dean RL; Ostrovsky-Day I; Deaver DR
Addict Biol; 2009 Sep; 14(4):408-18. PubMed ID: 19489752
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study.
Jayaram-Lindström N; Guterstam J; Häggkvist J; Ericson M; Malmlöf T; Schilström B; Halldin C; Cervenka S; Saijo T; Nordström AL; Franck J
Transl Psychiatry; 2017 Apr; 7(4):e1104. PubMed ID: 28440810
[TBL] [Abstract][Full Text] [Related]
9. The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone.
Spencer TJ; Bhide P; Zhu J; Faraone SV; Fitzgerald M; Yule AM; Uchida M; Spencer AE; Hall AM; Koster AJ; Feinberg L; Kassabian S; Storch B; Biederman J
J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29617066
[TBL] [Abstract][Full Text] [Related]
10. Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine.
Stoops WW; Pike E; Hays LR; Glaser PE; Rush CR
Pharmacol Biochem Behav; 2015 Feb; 129():45-50. PubMed ID: 25459104
[TBL] [Abstract][Full Text] [Related]
11. Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potential.
Reissig CJ; Harrison JA; Carter LP; Griffiths RR
Psychopharmacology (Berl); 2015 Mar; 232(5):871-83. PubMed ID: 25199955
[TBL] [Abstract][Full Text] [Related]
12. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
[TBL] [Abstract][Full Text] [Related]
13. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.
Rush CR; Stoops WW; Lile JA; Glaser PE; Hays LR
Psychopharmacology (Berl); 2011 Apr; 214(3):665-74. PubMed ID: 21072503
[TBL] [Abstract][Full Text] [Related]
14. Individual differences in responses to ethanol and d-amphetamine: a within-subject study.
Holdstock L; de Wit H
Alcohol Clin Exp Res; 2001 Apr; 25(4):540-8. PubMed ID: 11329494
[TBL] [Abstract][Full Text] [Related]
15. Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study.
Hamann S; Sloan P
J Opioid Manag; 2007; 3(3):137-44. PubMed ID: 18027539
[TBL] [Abstract][Full Text] [Related]
16. Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
Cooper ZD; Haney M
Psychopharmacology (Berl); 2010 Aug; 211(2):141-8. PubMed ID: 20490465
[TBL] [Abstract][Full Text] [Related]
17. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans.
Stoops WW; Glaser PE; Fillmore MT; Rush CR
J Psychopharmacol; 2004 Dec; 18(4):534-43. PubMed ID: 15582920
[TBL] [Abstract][Full Text] [Related]
18. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
Brauer LH; de Wit H
Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women.
Lile JA; Kendall SL; Babalonis S; Martin CA; Kelly TH
Pharmacol Biochem Behav; 2007; 87(2):258-66. PubMed ID: 17544491
[TBL] [Abstract][Full Text] [Related]
20. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.
Stoops WW; Vansickel AR; Lile JA; Rush CR
Pharmacol Biochem Behav; 2007 May; 87(1):20-9. PubMed ID: 17490738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
